Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Bone Marrow Diseases

methotrexate has been researched along with Bone Marrow Diseases in 100 studies

Research

Studies (100)

TimeframeStudies, this research(%)All Research%
pre-199050 (50.00)18.7374
1990's16 (16.00)18.2507
2000's10 (10.00)29.6817
2010's22 (22.00)24.3611
2020's2 (2.00)2.80

Authors

AuthorsStudies
Lien, YH; Tsai, HM1
Al Sabahi, A; Albiroty, K1
Ichikawa, T; Kishida, D; Otuki, T; Sekijima, Y; Shimojima, Y; Ueno, KI1
Matsuoka, Y; Narukawa, M1
Biju, IK; Manappallil, RG; Peringat, J; Prasan, D1
Carmichael, KE; Chan, BSH; Dimeski, G; Harris, K; Isoardi, KZ; Page, CB1
Angelopoulou, MK; Asimakopoulos, JV; Boutsikas, G; Kanellopoulos, A; Konstantinou, E; Konstantopoulos, K; Moschogiannis, M; Pangalis, GA; Petevi, K; Siakantaris, MP; Triantafyllou, EF; Vassilakopoulos, TP1
Burghardt, AJ; Cruz, A; Graf, J; Heilmeier, U; Imboden, JB; Li, X; Link, TM; Mamoto, K; Pedoia, V; Shimizu, T; Tanaka, M1
Kantarjian, HM1
Baker, DG; Baker, JF; Conaghan, PG; Emery, P; Hsia, EC; Lu, J; Ostergaard, M1
Charro, M; Domènech, E; García-López, S; Gisbert, JP; Gomollón, F; Muñoz, F; Rubio, S1
Chinello, M; Locasciulli, A; Naviglio, S; Severino, A; Shardlow, A; Ventura, A1
Ali, EA; Bilasy, SE; Essawy, SS; Mandour, MF; Zaitone, SA1
Carlsen, N; Christensen, IJ; Dalhoff, K; Gréen, H; Gregers, J; Lausen, B; Peterson, C; Rosthoej, S; Schmiegelow, K; Schroeder, H1
Nguyen, TT; Parker, BJ; Yachoui, R1
Chihara, D; Dang, NH; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Kwak, LW; Loghavi, S; McLaughlin, P; Medeiros, LJ; Miranda, RN; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, JE; Samaniego, F; Wang, M; Younes, A1
Bowes, MA; Bradley, JD; Conaghan, PG; Fuerst, T; Hrycaj, P; Irazoque-Palazuelos, F; Soma, K; Soto-Raices, O; van der Heijde, D; Wilkinson, B; Wu, C; Wyman, BT; Xie, Z; Zhang, R; Østergaard, M1
Dietrich, PY; Espeli, V; Hottinger, AF; Modarressi, A; Ruegg, E1
Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD1
Callen, JP; Kalajian, AH; Van Meter, JR1
Dybała, A; Mosiewicz, J; Myśliński, W; Prystupa, A; Zak, K1
Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M1
Goto, D; Hayashi, T; Ito, S; Matsumoto, I; Sumida, T1
Abbenante, MC; Baccarani, M; Curti, A; Iacobucci, I; Martinelli, G; Paolini, S; Papayannidis, C; Parisi, S1
Carretero-Hernández, G1
Bunjevacki, V; Damjanov, N; Damnjanovic, T; Jekic, B; Kovacevic, L; Krajinovic, M; Lukovic, L; Maksimovic, N; Milasin, J; Milic, V; Novakovic, I; Popovic, B; Radunovic, G1
Handa, S; Sosin, M1
Centurioni, R; Corvatta, L; Leoni, F; Leoni, P; Malerba, L; Marconi, M; Masia, MC; Mele, A; Offidani, M; Scortechini, A1
Clarke, AK1
Adkins, D; Blum, W; Brown, R; Chohan, R; Devine, S; DiPersio, JF; Goodnough, LT; Graubert, T; Khoury, H; Tomasson, M; Vij, R1
Lv, W; Mao, Y; Wan, X; Xie, X1
Gori, JL; Gunther, R; Karlen, AD; McIvor, RS; Podetz-Pedersen, K; Somia, NV; Swanson, D1
Behnam, K; Lee, JH; Lewis, GC; Looka, MH1
Rubin, P1
Duque-Hammershaimb, L; Miller, DR; Wollner, N1
Barber, SW; Camitta, BM; Casper, JT; Kamen, BA; Kaplan, BM; Kline, RW; Kun, LE; Lauer, SJ; Mulhern, RK1
Chessells, J; Leiper, A; Rogers, D1
Chessells, JM; Sandland, RM; Tiedemann, J1
Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Rivera, G; Wood, A1
Chu, BC; Howell, SB1
Geary, CG1
Howell, SB; Mansfield, SJ; Taetle, R1
Anderson, G; Bowyer, F; Williams, L1
Dreicer, R; Einhorn, LH; Elson, P; Hahn, R; Loehrer, PJ; Nichols, CR; Williams, R1
Capotorto, AM; Da Prada, GA; Lelli, G; Martoni, A; Pannuti, F; Pavesi, L; Pedrazzoli, P; Preti, P; Robustelli della Cuna, G; Zamagni, C1
Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A1
Amadori, S; Bocchia, M; Falini, B; Fiacchini, M; Martelli, M; Martelli, MF; Mazza, P; Papa, G; Pileri, S; Zinzani, PL1
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ1
Hosaka, M; Kondoh, I; Kubota, Y; Miura, T; Noguchi, S; Shuin, T1
Gunther, R; May, C; McIvor, RS1
Arnold, R; Aul, C; Büchner, T; Diedrich, H; Faak, T; Fabry, U; Fischer, K; Fonatsch, C; Freund, M; Fuhr, HG; Gassmann, W; Gökbuget, N; Gramatzki, M; Heil, G; Heinze, B; Heyll, A; Hiddemann, W; Hoelzer, D; Hossfeld, D; Ittel, TH; Koch, P; Kolbe, K; Kuse, R; Löffler, H; Ludwig, WD; Maschmeyer, G; Messerer, D; Metzner, B; Rieder, H; Schadeck-Gressel, C; Strohscheer, I; Thiel, E; Uberla, K; Völkers, B; Weiss, A1
Audouin, J; Bernadou, A; Chauvenet, L; Ciaudo, M; Favier, R; Horellou, MH; Rossert, J; Samama, M1
Chabner, BA; Treon, SP1
Date, Y; Kondo, H1
Bargay, J; Brunet, S; Caballero, D; de la Rubia, J; de la Serna, J; Domingo-Albós, A; Espigado, I; Figuera, A; García Conde, J; Hernández, F; Mataix, R; Moraleda, J; Ojeda, E; Pérez-Oteiza, J; Petit, J; Rozman, C; Sierra, J; Solano, C; Torrabadella, M; Urbano-Ispizua, A; Vivancos, P1
Burge, S; Sheerin, S; Stone, N1
Alarcón, GS; Chatham, WW; Morgan, SL1
Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE1
Aur, RJ; George, SL; Mauer, AM; Simone, JV1
Donaldson, MH; Meadows, AT; Morgan, E1
Bull, JM; Ingle, JN; Simon, RM; Tormey, DC1
Jensen, TS; Ogaard, S1
Morley, AA; Trainor, KJ1
Atiq, OT; Brennan, M; Chapman, D; Ginn, D; Heelan, R; Kelsen, D; Lightdale, C; Niedzwiecki, D; Saltz, L; Vinciguerra, V1
Ackerman, C; Goemaere, S; Mielants, H; Van der Straeten, C; Veys, EM1
Bleyer, WA; Coccia, PF; Finklestein, JZ; Hammond, GD; Littman, PS; Lukens, JN; Miller, DR; Nickerson, HJ; Sather, HN; Siegel, SE1
Anderson, H; Howell, A; Morton, AR1
Ashley, S; Powles, TI1
Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC1
Aabo, K; Bork, E; Bødker, B; Dombernowsky, P; Hansen, HH; Hansen, M; Malmberg, R; Sørensen, JB1
Bernard, A; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C1
Aguilar, N; Alberola, V; Benet, I; Carbonell, F; García-Conde, J; Lluch, A; Peñarroja, C; Ubeda, F1
Howland, WL1
He, GF; Zhao, TP1
Bernasconi, C; Brusamolino, E; Canevari, A; Inverardi, D; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G1
Gutterman, LA; Thomas, MH1
Russo, A; Schiliro', G1
Amadori, S; Anselmo, AP; Baroni, CD; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G1
Boyle, J; Daly, HM; Roberts, CJ; Scott, GL1
Baer, MR; Flexner, JM; Stein, RS1
George, SL; Mauer, AM; Ochs, JJ; Simone, JV1
Bitter, K1
Buckner, CD; Clift, RA; Evans, RS; Fefer, A; Neiman, P; Storb, R; Thomas, ED; Wright, SE1
Speck, B1
Bryant, JI; Buckner, CD; Clift, RA; Fefer, A; Fialkow, PJ; Funk, DD; Neiman, PE; Rudolph, RH; Slichter, SJ; Storb, R; Thomas, ED1
Crocker, DW; Piro, AJ; Shirley, RL1
Aghai, E; Hulu, N; Kende, G; Ramot, B; Virag, I1
Cowan, DH; Phillips, RA1
Massimo, L1
Douglas, ID; Price, LA1
Djerassi, I; Hughes, D; Kim, JS; Rominger, CJ; Suvansri, U; Turchi, J1
Boesen, EA1
Currey, HL1
Grob, PJ1
Vendrely, C; Wicart, L1
Ansfield, FJ; Carter, AC; Goldenberg, IS; Segaloff, A1
Burgess, MA; Gibson, OM; Stanley, LG1
Bagshawe, KD; Jackson, JG; Rawbone, RG; Shaw, MT1
Beretta, G; Bonadonna, G; De Lena, M; Fossati-Bellani, F; Monfardini, S1
Herbert, V; Waxman, S1

Reviews

9 review(s) available for methotrexate and Bone Marrow Diseases

ArticleYear
Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.
    Hematological oncology, 2019, Volume: 37, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Dexamethasone; Diagnostic Errors; Female; Humans; Immunotherapy; Injections, Spinal; Leukemia, Hairy Cell; Lymphoma, B-Cell, Marginal Zone; Male; Meninges; Methotrexate; Remission Induction; Rituximab; Splenic Neoplasms

2019
Bone and bone marrow involvement in sarcoidosis.
    Rheumatology international, 2015, Volume: 35, Issue:11

    Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging

2015
The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:1

    Topics: Antineoplastic Agents; Bleomycin; Bone Marrow Diseases; Brain Diseases; Cardiomyopathies; Carmustine; Cisplatin; Doxorubicin; Gastrointestinal Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Methotrexate; Neoplasms; Radiotherapy

1984
Concepts in use of high-dose methotrexate therapy.
    Clinical chemistry, 1996, Volume: 42, Issue:8 Pt 2

    Topics: Adult; Aging; Animals; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Child; Drug Monitoring; Humans; Methotrexate; Middle Aged; Neoplasms

1996
Bone marrow transplantation-clinical results and problems.
    Blut, 1973, Volume: 27, Issue:5

    Topics: Agammaglobulinemia; Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Cyclophosphamide; Graft vs Host Reaction; Histocompatibility Antigens; Histocompatibility Testing; Humans; Immunologic Deficiency Syndromes; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Methotrexate; Mosaicism; Prognosis; Rabbits; Sepsis; Tissue Donors; Transplantation, Homologous

1973
Human bone marrow transplantation.
    The Medical clinics of North America, 1972, Volume: 56, Issue:2

    Topics: Acute Disease; Bone Marrow Diseases; Bone Marrow Transplantation; Cell Differentiation; Cyclophosphamide; Graft Rejection; Graft vs Host Reaction; Hematopoietic System; Humans; Immune Sera; Immune System Diseases; Immunosuppression Therapy; Leukemia; Methotrexate; Tissue Donors; Transplantation Immunology; Transplantation, Homologous

1972
Chemotherapy of bronchial carcinoma.
    B.T.T.A. review, 1973, Volume: 3, Issue:2

    Topics: Animals; Antimetabolites; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Bronchial Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Fluorouracil; Humans; Methotrexate; Pleural Effusion; Prognosis; Vascular Diseases; Vena Cava, Superior; Vincristine

1973
Treatment of rheumatoid arthritis with cytotoxic and antimetabolic drugs.
    Transactions of the St. John's Hospital Dermatological Society, 1970, Volume: 56, Issue:2

    Topics: Alopecia; Aminopterin; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Bone Marrow Diseases; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Female; Herpes Zoster; Humans; Jaundice; Mechlorethamine; Mercaptopurine; Methotrexate

1970
[Current status of immunosuppressive therapy in non-neoplastic disorders].
    Schweizerische medizinische Wochenschrift, 1970, Apr-18, Volume: 100, Issue:16

    Topics: Arthritis; Autoimmune Diseases; Azathioprine; Bone Marrow; Bone Marrow Diseases; Chemical Phenomena; Chemistry; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Diseases; Methotrexate; Prognosis; Skin Diseases

1970

Trials

20 trial(s) available for methotrexate and Bone Marrow Diseases

ArticleYear
Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:11

    Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Diseases; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Edema; Female; Humans; Magnetic Resonance Imaging; Male; Metacarpophalangeal Joint; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Radiography; Synovitis; Wrist Joint

2014
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
    British journal of haematology, 2015, Volume: 171, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Male; Medication Adherence; Methotrexate; Middle Aged; Polyethylene Glycols; Remission Induction; Treatment Outcome; Vincristine; Young Adult

2015
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitati
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:6

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Bone Marrow; Bone Marrow Diseases; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Hand; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Synovitis; Treatment Outcome; Wrist Joint

2016
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:10

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Bone Marrow Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Epidemiologic Methods; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prognosis; Radiography; Remission Induction

2010
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.
    The hematology journal : the official journal of the European Haematology Association, 2003, Volume: 4, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Marrow Diseases; Burkitt Lymphoma; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Carriers; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infections; Leukemia, T-Cell; Life Tables; Liposomes; Male; Methotrexate; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Safety; Survival Analysis; Topotecan; Treatment Outcome

2003
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 98, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine

2007
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine

1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study.
    Tumori, 1994, Aug-31, Volume: 80, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Drug Administration Schedule; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Middle Aged; Mitomycins; Mitoxantrone; Recombinant Proteins; Treatment Outcome

1994
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine

1994
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Factors; Treatment Outcome; Vincristine

1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Blood, 1995, Jul-15, Volume: 86, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1995
The value of maintenance therapy following treatment of central nervous system leukemia.
    Cancer, 1977, Volume: 40, Issue:3

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Brain Neoplasms; Child; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Remission, Spontaneous; Retrospective Studies; Spinal Cord Neoplasms; Time Factors

1977
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Prospective Studies; Stomach Neoplasms; Survival Analysis

1992
The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    The Journal of rheumatology, 1991, Volume: 18, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blood Sedimentation; Bone Marrow Diseases; C-Reactive Protein; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Kidney Failure, Chronic; Liver; Male; Methotrexate; Middle Aged; Prospective Studies

1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Random Allocation; Recurrence; Remission Induction; Survival Rate; Testicular Neoplasms; Vincristine

1991
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Random Allocation; Vindesine

1987
The enigma of testicular leukemia: a critical review.
    Medical and pediatric oncology, 1986, Volume: 14, Issue:6

    Topics: Animals; Bone Marrow Diseases; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Nervous System Neoplasms; Prognosis; Rats; Research Design; Sex Factors; Testicular Neoplasms

1986
The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Methotrexate; Nervous System Neoplasms; Prognosis; Radiotherapy Dosage

1985
Treatment of rheumatoid arthritis with cytotoxic and antimetabolic drugs.
    Transactions of the St. John's Hospital Dermatological Society, 1970, Volume: 56, Issue:2

    Topics: Alopecia; Aminopterin; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Bone Marrow Diseases; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Female; Herpes Zoster; Humans; Jaundice; Mechlorethamine; Mercaptopurine; Methotrexate

1970
[Protective effect of highly polymerized deoxyribonucleic acid against bone marrow aplasia following intense anti-cancer chemotherapy or radiocobalt irradiation].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1967, Feb-06, Volume: 264, Issue:6

    Topics: Anemia, Aplastic; Bone Marrow Diseases; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cobalt Isotopes; DNA; Humans; Meningioma; Methotrexate

1967

Other Studies

72 other study(ies) available for methotrexate and Bone Marrow Diseases

ArticleYear
Stomatitis and Bone Marrow Suppression Followed by Leukoerythroblastosis in a Patient on Long-Term Low-Dose Methotrexate Therapy.
    The American journal of medicine, 2022, Volume: 135, Issue:11

    Topics: Bone Marrow; Bone Marrow Diseases; Humans; Methotrexate; Stomatitis

2022
Severe Recurrent Nocturnal Hypoglycemia During Chemotherapy With 6-mercaptopurine in 2 Children With Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2023, 04-01, Volume: 45, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Female; Humans; Hypoglycemia; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2023
Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
    Internal medicine (Tokyo, Japan), 2019, Dec-01, Volume: 58, Issue:23

    Topics: Aged; Antibodies, Monoclonal, Humanized; Bone Marrow Diseases; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Still's Disease, Adult-Onset; Tacrolimus

2019
Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database.
    Therapeutic innovation & regulatory science, 2018, Volume: 52, Issue:3

    Topics: Adverse Drug Reaction Reporting Systems; Antirheumatic Agents; Bone Marrow Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Interleukin-6; Japan; Methotrexate; Neoplasms; Odds Ratio; Time Factors; Tuberculosis; Tumor Necrosis Factor-alpha

2018
Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.
    BMJ case reports, 2018, Jun-05, Volume: 2018

    Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Cells; Bone Marrow Diseases; Diclofenac; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Methotrexate; Oral Ulcer

2018
Acute bone marrow suppression and gastrointestinal toxicity following acute oral methotrexate overdose.
    Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:12

    Topics: Anti-Bacterial Agents; Antirheumatic Agents; Azabicyclo Compounds; Blood Transfusion; Bone Marrow Diseases; Drug Overdose; Febrile Neutropenia; Female; Filgrastim; Gastrointestinal Diseases; Humans; Leucovorin; Methotrexate; Middle Aged; Mucositis; Piperazines; Suicide, Attempted; Tramadol

2018
Structural Changes over a Short Period Are Associated with Functional Assessments in Rheumatoid Arthritis.
    The Journal of rheumatology, 2019, Volume: 46, Issue:7

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Bone Marrow Diseases; Edema; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Surveys and Questionnaires; Synovitis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha

2019
Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia.
    Clinical advances in hematology & oncology : H&O, 2019, Volume: 17, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Bispecific; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Dexamethasone; Humans; Inotuzumab Ozogamicin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Vascular Diseases

2019
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:1

    Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Nausea; Ondansetron

2015
Dysplastic bone marrow changes during maintenance therapy for acute leukemia.
    Journal of pediatric hematology/oncology, 2015, Volume: 37, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Disease Management; Female; Follow-Up Studies; Humans; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis

2015
Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Cell Count; Bone Marrow; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cytokines; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Hindlimb; Isoxazoles; Leflunomide; Liver Cirrhosis; Male; Methotrexate; Rats; Rats, Wistar; Spleen

2015
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.
    The pharmacogenomics journal, 2015, Volume: 15, Issue:4

    Topics: Acute Disease; Adolescent; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Denmark; Genotype; Haplotypes; Humans; Infant; Male; Methotrexate; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Recurrence; Risk Assessment; Treatment Outcome

2015
Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
    Anticancer research, 2016, Volume: 36, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Renal Insufficiency; Retrospective Studies; Salvage Therapy; Skin Neoplasms

2016
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
    The British journal of dermatology, 2016, Volume: 175, Issue:1

    Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination

2016
Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil.
    Archives of dermatology, 2009, Volume: 145, Issue:8

    Topics: Adult; Anemia; Bone Marrow Diseases; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Leukopenia; Male; Methotrexate; Mycophenolic Acid; Sarcoidosis; Skin Diseases

2009
[Pancytopenia after methotrexate treatment].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2009, Volume: 62, Issue:2

    Topics: Aged; Bone Marrow Diseases; Fatal Outcome; Female; Humans; Liver Failure; Methotrexate; Pancytopenia; Spinal Diseases

2009
Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
    Modern rheumatology, 2010, Volume: 20, Issue:6

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow; Bone Marrow Diseases; Creatinine; Cystatin C; Female; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prospective Studies; Renal Insufficiency

2010
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Bone Marrow Diseases; Diagnosis, Differential; Doxorubicin; Humans; Ischemia; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Myelitis, Transverse; Paraplegia; Paresthesia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Spinal Cord; Vincristine

2010
Methotrexate in psoriasis: do we need to give a test dose?
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:1

    Topics: Bone Marrow Diseases; Dose-Response Relationship, Drug; Drug Eruptions; Drug Hypersensitivity; Folic Acid; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Methotrexate; Pneumonia; Practice Guidelines as Topic; Psoriasis; Stomatitis, Aphthous

2012
Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow; Bone Marrow Diseases; Chi-Square Distribution; Cyclin D1; Female; gamma-Glutamyl Hydrolase; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Risk Factors; Severity of Illness Index; Thymidylate Synthase; Young Adult

2013
Low dose methotrexate and bone marrow suppression.
    BMJ (Clinical research ed.), 2003, Feb-01, Volume: 326, Issue:7383

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Diseases; Fatal Outcome; Female; Humans; Male; Medication Errors; Methotrexate

2003
Methotrexate and bone marrow suppression: standard collaborative care will be made more difficult.
    BMJ (Clinical research ed.), 2003, May-24, Volume: 326, Issue:7399

    Topics: Antirheumatic Agents; Bone Marrow Diseases; Drug Therapy, Combination; Humans; Medication Errors; Methotrexate

2003
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
    British journal of haematology, 2003, Volume: 123, Issue:1

    Topics: Adult; Bone Marrow Diseases; Bone Marrow Transplantation; Brain; Calcineurin Inhibitors; Central Nervous System Diseases; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Transplantation, Homologous

2003
Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:3

    Topics: Animals; Antidotes; Bone Marrow Diseases; Bone Marrow Transplantation; Drug Resistance; Genetic Vectors; Hematocrit; Lentivirus; Methotrexate; Mice; Mice, Inbred C57BL; Mutation; Tetrahydrofolate Dehydrogenase; Transduction, Genetic

2007
Treatment of cervical carcinoma with methotrexate, bleomycin and vincristine.
    Cancer clinical trials, 1981, Volume: 4, Issue:1

    Topics: Adult; Aged; Bleomycin; Bone Marrow Diseases; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Uterine Cervical Neoplasms; Vincristine

1981
LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
    Cancer, 1983, Jul-01, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Methotrexate; Prednisone; Prognosis; Time Factors; Vincristine

1983
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5

    Topics: Acute Disease; Bone Marrow Diseases; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immune Tolerance; Infant; Injections, Spinal; Intelligence Tests; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methods; Methotrexate; Recurrence

1984
Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Diseases; Brain; Central Nervous System Diseases; Child; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Spinal Cord; Testicular Neoplasms; Time Factors

1984
Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome.
    British medical journal (Clinical research ed.), 1982, Dec-04, Volume: 285, Issue:6355

    Topics: Adolescent; Bone Marrow Diseases; Child; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Male; Methotrexate; Prognosis; Recurrence; Testicular Neoplasms

1982
VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Cancer, 1980, Oct-15, Volume: 46, Issue:8

    Topics: Adolescent; Antineoplastic Agents; Bone Marrow Diseases; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Podophyllotoxin; Remission, Spontaneous; Teniposide

1980
Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 219, Issue:2

    Topics: Animals; Bone Marrow Diseases; Female; Injections; Kinetics; Leucovorin; Leukemia L1210; Methotrexate; Mice; Pleura; Polylysine; Serum Albumin, Bovine

1981
Lymphoma and leukaemia due to drugs.
    British journal of hospital medicine, 1980, Volume: 24, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bone Marrow Diseases; Child; Female; Hodgkin Disease; Humans; Immunosuppression Therapy; Kidney; Kidney Transplantation; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methotrexate

1980
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate.
    Cancer chemotherapy and pharmacology, 1981, Volume: 5, Issue:4

    Topics: Blood Proteins; Bone Marrow Diseases; Colony-Forming Units Assay; Humans; Methotrexate; Protein Binding; Thymidine

1981
Oral VP-16-213 in advanced bronchogenic carcinoma and toxic effects when combined with methotrexate.
    Thorax, 1981, Volume: 36, Issue:6

    Topics: Bone Marrow Diseases; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Podophyllotoxin; Vincristine

1981
Schedule-intensified M-VAC chemotherapy for advanced urothelial cancer with recombinant human granulocyte colony stimulating factor (rhG-CSF).
    International journal of urology : official journal of the Japanese Urological Association, 1994, Volume: 1, Issue:2

    Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Urologic Neoplasms; Vinblastine

1994
Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Animals; Bone Marrow; Bone Marrow Diseases; Bone Marrow Transplantation; Drug Resistance; Female; Gastrointestinal Diseases; Ileum; Intestinal Mucosa; Methotrexate; Mice; Mice, Transgenic; Microvilli; Radiation Chimera; Radiation Injuries, Experimental; Recombinant Proteins; Tetrahydrofolate Dehydrogenase; Whole-Body Irradiation

1995
Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Blood, 1996, Jan-15, Volume: 87, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Leukemic Infiltration; Male; Meninges; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stomatitis; Survival Analysis; Survival Rate; Teniposide; Treatment Outcome; Vincristine

1996
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
    Leukemia & lymphoma, 1995, Volume: 19, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Peripheral; Methotrexate; Mitoguazone; Prednisone; Teniposide; Verapamil; Vincristine; Vindesine

1995
Benefit of simultaneous rhG-CSF and methylprednisolone 'pulse' therapy for methotrexate-induced bone marrow failure in rheumatoid arthritis.
    International journal of hematology, 1997, Volume: 65, Issue:2

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Diseases; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Methylprednisolone; Recombinant Proteins

1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
    Sangre, 1997, Volume: 42 Suppl 1

    Topics: Adolescent; Adult; Bone Marrow Diseases; Female; Graft Rejection; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Homologous

1997
Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
    Clinical and experimental dermatology, 1999, Volume: 24, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Diagnosis, Differential; Diarrhea; Fatal Outcome; Fever; Graft vs Host Disease; Humans; Liver Failure; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency; Stevens-Johnson Syndrome

1999
Renal failure: a risk factor for methotrexate toxicity.
    Arthritis and rheumatism, 2000, Volume: 43, Issue:5

    Topics: Bone Marrow Diseases; Female; Humans; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Renal Dialysis; Risk Factors

2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:5A

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2000
A reappraisal of the results of stopping therapy in childhood leukemia.
    The New England journal of medicine, 1979, Feb-08, Volume: 300, Issue:6

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Central Nervous System; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Probability; Recurrence; Remission, Spontaneous; Risk; Sex Factors; Testicular Neoplasms; Time Factors

1979
Bone marrow involvement in breast cancer: effect on response and tolerance to combination chemotherapy.
    Cancer, 1977, Volume: 39, Issue:1

    Topics: Adult; Aged; Blood Cell Count; Blood Platelets; Bone Marrow Diseases; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous

1977
[Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ugeskrift for laeger, 1977, Feb-28, Volume: 139, Issue:9

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Diseases; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Time Factors; Vincristine

1977
Screening of cytotoxic drugs for residual bone marrow damage.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:6

    Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Busulfan; Carmustine; Cell Survival; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fluorouracil; Hematopoietic Stem Cells; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Vinblastine

1976
Myelotoxicity of methotrexate, mitozantrone, and mitomycin C.
    Lancet (London, England), 1987, Jun-27, Volume: 1, Issue:8548

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone

1987
Myelosuppression after methotrexate, mitozantrone, and mitomycin C combination chemotherapy.
    Lancet (London, England), 1987, Oct-10, Volume: 2, Issue:8563

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Humans; Methotrexate; Mitomycin; Mitomycins; Mitoxantrone

1987
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
    Cancer treatment reports, 1985, Volume: 69, Issue:2

    Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine

1985
High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma: phase II studies and their use in further protocols.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Diseases; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine

1986
[Toxicity and hematopoietic regeneration produced by adjuvant chemotherapy in patients with neoplasia of the breast].
    Sangre, 1988, Volume: 33, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Diseases; Breast Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Doxorubicin; Female; Hematopoiesis; Humans; Methotrexate; Middle Aged

1988
Methotrexate-associated bone marrow suppression following surgery.
    Arthritis and rheumatism, 1988, Volume: 31, Issue:12

    Topics: Aged; Arthritis, Rheumatoid; Bone Marrow Diseases; Humans; Male; Methotrexate; Postoperative Complications

1988
A phase II clinical trial of flutamide in the treatment of advanced breast cancer.
    Tumori, 1988, Feb-29, Volume: 74, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Injections, Intravenous; Methotrexate; Nausea; Pilot Projects; Vomiting

1988
Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Meningeal Neoplasms; Methotrexate; Middle Aged

1986
Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.
    The Journal of rheumatology, 1986, Volume: 13, Issue:2

    Topics: Arthritis, Rheumatoid; Bone Marrow Diseases; Drug Combinations; Drug Interactions; Female; Humans; Methotrexate; Middle Aged; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1986
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
    Cancer investigation, 1987, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine

1987
Methotrexate toxicity precipitated by azapropazone.
    The British journal of dermatology, 1986, Volume: 114, Issue:6

    Topics: Adult; Apazone; Bone Marrow Diseases; Drug Interactions; Female; Humans; Joint Diseases; Methotrexate; Psoriasis; Triazines

1986
Improved survival in adult acute lymphoblastic leukemia. Need for more effective CNS prophylaxis.
    American journal of clinical oncology, 1985, Volume: 8, Issue:2

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Nervous System Neoplasms; Prednisone; Time Factors; Vincristine

1985
[Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin].
    Deutsche Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt fur die gesamte Zahn-, Mund-, und Kieferheilkunde, 1973, Volume: 60, Issue:2

    Topics: Antibiotics, Antineoplastic; Bleomycin; Bone Marrow Diseases; Carcinoma, Squamous Cell; Drug Synergism; Humans; Maxillary Neoplasms; Methotrexate; Mouth Neoplasms; Pulmonary Fibrosis; Remission, Spontaneous

1973
Paroxysmal nocturnal haemoglobinuria and refractory marrow failure treated by marrow transplantation.
    British journal of haematology, 1973, Volume: 24, Issue:6

    Topics: Adult; Benzene; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Cyclophosphamide; Graft vs Host Reaction; Hemoglobinuria, Paroxysmal; Histocompatibility Antigens; Humans; Male; Methotrexate; Poisoning; Transplantation, Homologous

1973
Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
    Transactions of the Association of American Physicians, 1971, Volume: 84

    Topics: Animals; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Dogs; Female; Graft vs Host Reaction; Histocompatibility; Histocompatibility Antigens; Histocompatibility Testing; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Methotrexate; Radiation Chimera; Sex Factors; Tissue Donors; Transplantation, Homologous

1971
Malignant neural elements in a benign cystic teratoma. A case report.
    Obstetrics and gynecology, 1971, Volume: 37, Issue:3

    Topics: Adult; Antineoplastic Agents; Bone Marrow Diseases; Cyclophosphamide; Dactinomycin; Dermoid Cyst; Female; Glioblastoma; Humans; Liver Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Ovarian Neoplasms; Radiography; Teratoma; Ureteral Neoplasms; Vincristine

1971
Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.
    Cancer, 1974, Volume: 33, Issue:5

    Topics: Abdominal Neoplasms; Adolescent; Age Factors; Allopurinol; Antigens, Viral; Arabia; Bone Marrow Diseases; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Ethnicity; Female; Herpesvirus 4, Human; Humans; Israel; Jaw Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine

1974
[Role of daunomycin in the treatment of acute leukemia in children].
    Minerva medica, 1972, Mar-31, Volume: 63, Issue:24

    Topics: Bone Marrow Diseases; Child; Daunorubicin; Dexamethasone; Drug Synergism; Evaluation Studies as Topic; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Vincristine

1972
Bone-marrow toxicity of methotrexate: a reassessment.
    British journal of haematology, 1973, Volume: 24, Issue:5

    Topics: Administration, Oral; Blood Platelets; Bone Marrow Cells; Bone Marrow Diseases; Child; Hemoglobinometry; Humans; Injections, Intra-Arterial; Injections, Intramuscular; Injections, Intravenous; Leukemia, Lymphoid; Leukocyte Count; Methotrexate; Models, Biological; Regeneration; Time Factors

1973
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
    Cancer, 1972, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Adult; Bone Marrow Diseases; Carcinoma, Squamous Cell; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Radiography

1972
Phase I study of phenesterin (NSC-104469).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:3

    Topics: Administration, Oral; Adult; Aged; Androgens; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Bone Marrow Diseases; Breast Neoplasms; Chlorambucil; Cholestanes; Cyclophosphamide; Estrogens; Fluorouracil; Glucocorticoids; Humans; Leukocyte Count; Leukopenia; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Secosteroids; Stomatitis; Tachycardia; Thiotepa; Vincristine

1971
Cytogenetic remission in acute transformation of chronic granulocytic leukaemia.
    British medical journal, 1969, May-31, Volume: 2, Issue:5656

    Topics: Acute Disease; Aged; Aneuploidy; Bone Marrow Diseases; Busulfan; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Disorders; Chronic Disease; Female; Humans; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Prednisolone; Vincristine

1969
Complication of methotrexate-maintained remission in lymphoblastic leukemia.
    British medical journal, 1971, Nov-20, Volume: 4, Issue:5785

    Topics: Ampicillin; Bone Marrow Diseases; Child; Cloxacillin; Female; Humans; Inhalation; Injections, Intramuscular; Leucovorin; Leukemia, Lymphoid; Lung; Methotrexate; Pneumonia; Prednisone; Remission, Spontaneous; Vincristine

1971
Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).
    Cancer research, 1970, Volume: 30, Issue:10

    Topics: Adolescent; Adult; Aged; Alopecia; Anthraquinones; Antibiotics, Antineoplastic; Bone Marrow Diseases; Child; Child, Preschool; Female; Humans; Leukemia; Male; Methotrexate; Middle Aged; Neoplasms; Prednisolone; Stomatitis; Time Factors; Vincristine

1970
Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
    The New England journal of medicine, 1969, Jun-12, Volume: 280, Issue:24

    Topics: Anemia, Macrocytic; Bone Marrow; Bone Marrow Diseases; Chorioretinitis; Culture Techniques; Deoxyuridine; DNA; Erythrocytes; Female; Fluorouracil; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Middle Aged; Nucleotides; Oxidation-Reduction; Pyrimethamine; Thymidine; Tritium

1969